DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis

Science Signaling

Volumn 8, Issue 369, 2015, Pages

  Zhang, Yan ^a   Su, Jin ^b   Wu, Shufang ^a   Teng, Yue ^a   Yin, Zhanhai ^a   Guo, Yan ^c   Li, Jing ^a   Li, Kun ^d   Yao, Libo ^b   Li, Xu ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d Clinical Laboratory ShanXi Mineral Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISCOIDIN DOMAIN RECEPTOR 2; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; NEUROPILIN 1; PLEXINA1 PROTEIN; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN; TREM2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DISCOIDIN RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LECTIN RECEPTOR; MEMBRANE PROTEIN; NERVE PROTEIN; PLXNA1 PROTEIN, MOUSE; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TREM2 PROTEIN, MOUSE; TYROBP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MATRIX; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; GENE TARGETING; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA INTERFERENCE; ANIMAL; BONE DEVELOPMENT; CELL LINE; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; OSTEOBLAST; OVARIECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOVIRIDAE; MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; NERVE TISSUE PROTEINS; NEUROPILIN-1; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PROTEIN BINDING; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, MITOGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84925449899     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005835     Document Type: Article

References (42)

1. D. L. Diab, N. B. Watts, Diagnosis and treatment of osteoporosis in older adults. Endocrinol. Metab. Clin. North Am. 42, 305-317 (2013).
2. P. R. Ebeling, Vitamin D and bone health: Epidemiologic studies. Bonekey Rep. 3, 511 (2014).
3. P. Gerdhem, Osteoporosis and fragility fractures: Vertebral fractures. Best Pract. Res. Clin. Rheumatol. 27, 743-755 (2013).
4. M. Kawai, U. I. Mödder, S. Khosla, C. J. Rosen, Emerging therapeutic opportunities for skeletal restoration. Nat. Rev. Drug Discov. 10, 141-156 (2011).
5. T. Komori, Signaling networks in RUNX2-dependent bone development. J. Cell. Biochem. 112, 750-755 (2011).
6. M. C. Horowitz, J. A. Lorenzo, The origins of osteoclasts. Curr. Opin. Rheumatol. 16, 464-468 (2004).
7. A. Shrivastava, C. Radziejewski, E. Campbell, L. Kovac, M. McGlynn, T. E. Ryan, S. Davis, M. P. Goldfarb, D. J. Glass, G. Lemke, G. D. Yancopoulos, An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell 1, 25-34 (1997).
8. W. Vogel, G. D. Gish, F. Alves, T. Pawson, The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1, 13-23 (1997).
9. O. Ichikawa, M. Osawa, N. Nishida, N. Goshima, N. Nomura, I. Shimada, Structural basis of the collagen-binding mode of discoidin domain receptor 2. EMBO J. 26, 4168-4176 (2007).
10. E. Olaso, H.-C. Lin, L.-H. Wang, S. L. Friedman, Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling. Fibrogenesis Tissue Repair 4, 5 (2011).
11. S. Zhang, X. Bu, H. Zhao, J. Yu, Y. Wang, D. Li, C. Zhu, T. Zhu, T. Ren, X. Liu, L. Yao, J. Su, A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis. J. Pathol. 232, 436-448 (2014).
12. H. Matsumura, K. Kano, C. Marín de Evsikova, J. A. Young, P. M. Nishina, J. K. Naggert, K. Naito, Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function. Physiol. Genomics 39, 120-129 (2009).
13. K. Kano, C. Marín de Evsikova, J. Young, C. Wnek, T. P. Maddatu, P. M. Nishina, J. K. Naggert, A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol. Endocrinol. 22, 1866-1880 (2008).
14. K. Kano, A. Kitamura, T. Matsuwaki, M. Morimatsu, K. Naito, Discoidin domain receptor 2 (DDR2) is required formaintenance of spermatogenesis in malemice. Mol. Reprod. Dev. 77, 29-37 (2010).
15. C. Mihai, D. F. Iscru, L. J. Druhan, T. S. Elton, G. Agarwal, Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type 1. J. Mol. Biol. 361, 864-876 (2006).
16. A. R. Blissett, D. Garbellini, E. P. Calomeni, C. Mihai, T. S. Elton, G. Agarwal, Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2. J. Mol. Biol. 385, 902-911 (2009).
17. K. Zhang, C. A. Corsa, S. M. Ponik, J. L. Prior, D. Piwnica-Worms, K. W. Eliceiri, P. J. Keely, G. D. Longmore, The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat. Cell Biol. 15, 677-687 (2013).
18. Z. Yan, S. Jin, Z. Wei, H. Huilian, Y. Zhanhai, T. Yue, L. Juan, L. Jing, Y. Libo, L. Xu, Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein. Biochim. Biophys. Acta 1842, 1350-1363 (2014).
19. Y. Zhang, J. Su, J. Yu, X. Bu, T. Ren, X. Liu, L. Yao, An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J. Bone Miner. Res. 26, 604-617 (2011).
20. K.-L. Lin, C.-H. Chou, S.-C. Hsieh, S.-Y. Hwa, M.-T. Lee, F.-F. Wang, Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. J. Bone Miner. Res. 25, 2489-2503 (2010).
21. Y. Guo, T.-L. Yang, S.-S. Dong, H. Yan, R.-H. Hao, X.-F. Chen, J.-B. Chen, Q. Tian, J. Li, H. Shen, H.-W. Deng, Genetic analysis identifies DDR2 as a novel gene affecting bone mineral density and osteoporotic fractures in Chinese population. PLOS One 10, e0117102 (2015).
22. C. Chen, M. Li, H. Chai, H. Yang, W. E. Fisher, Q. Yao, Roles of neuropilins in neuronal development, angiogenesis, and cancers. World J. Surg. 29, 271-275 (2005).
23. S. Koch, Neuropilin signalling in angiogenesis. Biochem. Soc. Trans. 40, 20-25 (2012).
24. M. Sarris, K. G. Andersen, F. Randow, L. Mayr, A. G. Betz, Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28, 402-413 (2008).
25. B. Chaudhary, Y. S. Khaled, B. J. Ammori, E. Elkord, Neuropilin 1: Function and therapeutic potential in cancer. Cancer Immunol. Immunother. 63, 81-99 (2014).
26. G. Neufeld, O. Kessler, The semaphorins: Versatile regulators of tumour progression and tumour angiogenesis. Nat. Rev. Cancer 8, 632-645 (2008).
27. N. Takegahara, H. Takamatsu, T. Toyofuku, T. Tsujimura, T. Okuno, K. Yukawa, M. Mizui, M. Yamamoto, D. V. R. Prasad, K. Suzuki, M. Ishii, K. Terai, M. Moriya, Y. Nakatsuji, S. Sakoda, S. Sato, S. Akira, K. Takeda, M. Inui, T. Takai, M. Ikawa, M. Okabe, A. Kumanogoh, H. Kikutani, Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 8, 615-622 (2006).
28. M. Hayashi, T. Nakashima, M. Taniguchi, T. Kodama, A. Kumanogoh, H. Takayanagi, Osteoprotection by semaphorin 3A. Nature 485, 69-74 (2012).
29. O. Söderberg, M. Gullberg, M. Jarvius, K. Ridderstråle, K.-J. Leuchowius, J. Jarvius, K. Wester, P. Hydbring, F. Bahram, L.-G. Larsson, U. Landegren, Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000 (2006).
30. E. Geretti, A. Shimizu, M. Klagsbrun, Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11, 31-39 (2008).
31. A. Kiedzierska, K. Smietana, H. Czepczynska, J. Otlewski, Structural similarities and functional diversity of eukaryotic discoidin-like domains. Biochim. Biophys. Acta 1774, 1069-1078 (2007).
32. N. Nagy, I. B. Németh, G. Szabad, G. Szolnoky, N. Belsõ, Z. Bata-Csörgõ, A. Dobozy, L. Kemény, M. Széll, The altered expression of syndecan 4 in the uninvolved skin of venous leg ulcer patients may predispose to venous leg ulcer. Wound Repair Regen. 16, 495-502 (2008).
33. A. Sijaona, K. Luukko, I. H. Kvinnsland, P. Kettunen, Expression patterns of Sema3F, PlexinA4, -A3, Neuropilin1 and -2 in the postnatal mouse molar suggest roles in tooth innervation and organogenesis. Acta Odontol. Scand. 70, 140-148 (2012).
34. S. Løes, P. Kettunen, I. H. Kvinnsland, M. Taniguchi, H. Fujisawa, K. Luukko, Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth. Mech. Dev. 101, 191-194 (2001).
35. R. L. Stouffer, J. C. Martínez-Chequer, T. A. Molskness, F. Xu, T. M. Hazzard, Regulation and action of angiogenic factors in the primate ovary. Arch. Med. Res. 32, 567-575 (2001).
36. P. Giacobini, J. Parkash, C. Campagne, A. Messina, F. Casoni, C. Vanacker, F. Langlet, B. Hobo, G. Cagnoni, S. Gallet, N. K. Hanchate, D. Mazur, M. Taniguchi, M. Mazzone, J. Verhaagen, P. Ciofi, S. G. Bouret, L. Tamagnone, V. Prevot, Brain endothelial cells control fertility through ovarian-steroid-dependent release of semaphorin 3A. PLOS Biol. 12, e1001808 (2014).
37. Y. Glinka, S. Stoilova, N. Mohammed, G. J. Prud'homme, Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis 32, 613-621 (2011).
38. Cas. Biochem. J. 435, 609-618 (2011).
39. B. Hu, P. Guo, I. Bar-Joseph, Y. Imanishi, M. J. Jarzynka, O. Bogler, T. Mikkelsen, T. Hirose, R. Nishikawa, S. Y. Cheng, Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26, 5577-5586 (2007).
40. S. Rizzolio, N. Rabinowicz, E. Rainero, L. Lanzetti, G. Serini, J. Norman, G. Neufeld, L. Tamagnone, Neuropilin-1-dependent regulation of EGF-receptor signaling. Cancer Res. 72, 5801-5811 (2012).
41. Y. Zhang, P. Liu, J. Li, K. Li, Y. Teng, X. Wang, X. Li, Communication factors-promising targets in osteoporosis treatment. Curr. Drug Targets 15, 156-163 (2014).
42. N. Takahashi, A. Muto, A. Arai, T. Mizoguchi, Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. Adv. Exp. Med. Biol. 658, 21-30 (2010).